_256_384.jpg)
News | January 21, 2025
Briefs: Cipla and IOL Chemicals and Pharmaceuticals
Mesalazine is used to treat inflammatory bowel disease
Mesalazine is used to treat inflammatory bowel disease
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
US Generics grew 5% to Rs. 467 Crores for the quarter
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
The inspection concluded with the issuance of a form 483 with five observations
Subscribe To Our Newsletter & Stay Updated
